The risk of a serious blood clot from AstraZeneca jab has doubled in a fortnight, new data show. Cases have gone up from 79 to 168 and deaths from 19 to 32. The chance of having a clot following vaccination has gone from one in 250,000 to one in 126,582.
Seven people suffered from partial paralysis after receiving the Sinovac vaccine, a doctor from Chulalongkorn University said. Six of them were in Rayong and one at the Queen Savang Vadhana Memorial Hospital in Chon Buri’s Sri Racha district. Their conditions improved after doctors administered medication to dissolve blood clots.
The Centers for Disease Control and Prevention is recommending that people who experience certain new symptoms after receiving Johnson & Johnson’s Covid-19 vaccine seek immediate medical treatment. The symptoms include sudden, severe headache, backache, new neurological symptoms, severe abdominal pain, shortness of breath, leg swelling, tiny red spots on the skin, and new or easy bruising.
While Johnson & Johnson’s vaccine is still authorized, the pause gives scientists time to review data and determine whether the vaccine is actually linked to the blood clots and, if so, whether recommendations on who should receive it should change.
55-year-old Augusta Turiaco, from Messina, Sicily, received her COVID jab on 11 March before her condition worsened in the days following her vaccination. The music teacher was keen to receive a jab as she worked with young people and even expressed her joy at getting the dose in a Facebook post, writing “fatto” – the Italian word for “done”.
See also “Hippocratic Oath” on Wikipedia
It is often said that the exact phrase “First do no harm” (Latin: Primum non nocere) is a part of the original Hippocratic oath. Although the phrase does not appear in the AD 245 version of the oath, similar intentions are vowed by, “I will abstain from all intentional wrong-doing and harm”. The phrase primum non nocere is believed to date from the 17th century.
Another equivalent phrase is found in Epidemics, Book I, of the Hippocratic school: “Practice two things in your dealings with disease: either help or do not harm the patient”.
The TGA’s Vaccine Safety Investigation Group (VSIG) met late today and concluded that a recently reported case of thrombosis (blood clots in the arteries and veins) with thrombocytopenia (low platelet count) is likely to be linked to vaccination. VSIG reviewed a report about a 48-year-old woman who was vaccinated in New South Wales and admitted to hospital with an extensive thromboembolic event and thrombocytopenia (TTS) four days after receiving the AstraZeneca COVID-19 Vaccine. Sadly,
this person Genene Norris died in hospital and we extend our sincerest condolences to her family.
RIP Genene Norris
Nine new cases of atypical thrombosis (clots) and two cases of coagulation disorders associated with AstraZeneca’s Covid-19 vaccine, with four additional deaths, occurred in France between April 2 and April 8, according to French health authorities. The nine new cases of rare thrombosis concern people who present “a profile different from that” of the cases declared previously, notes the ANSM. The age of the patients is “higher”: “It is about four women and five men, older (average age of 62 years) who presented more digestive thromboses.
Marie-Antoinette Sevestre-Pietri, French Society of Vascular Medicine President: “”In the long term, it will probably be necessary to do without adenovirus vaccines”
“Up to 5 April 2021, the MHRA had received Yellow Card reports of 100 cases of major thromboembolic events (blood clots) with concurrent thrombocytopenia (low platelet counts) in the UK following vaccination with COVID-19 Vaccine AstraZeneca. These events occurred in 61 women and 39 men aged from 18 to 85 years and the overall case fatality rate was 22% with 22 deaths.
Of these, 99 reports were associated with the first dose of the vaccine and a single report followed a second dose, although this individual had medical conditions that could have caused the events. Fifty individuals had cerebral venous sinus thrombosis (average age 46 years) and 50 had other major thromboembolic events (average age 52 years) with concurrent thrombocytopenia.”
Australian Federal health authorities are investigating the death of a 48-year-old New South Wales woman who developed blood clots after receiving a COVID-19 vaccine. If it is confirmed the woman contracted blood clots linked to a COVID-19 vaccine, it would be the third such case in Australia since the rollout began.
Denmark has received the first claim for compensation for a death caused by a special type of blood clot, which the authorities link with the Astrazeneca vaccine. The patient compensation scheme has received a total of 29 compensation applications from citizens who have received the Astrazeneca vaccine. A further eight cases concern the Pfizer vaccine. There are no claims for Moderna.
This is stated by Patienterstatningen, which handles cases of compensation for citizens who are affected by serious side effects from e.g. medicines.
After her first vaccination with Astrazeneca, the 43-year-old nurse Tina Sylvester Rohrmann from Nyborg was hit by blood clots in her lungs. She is sure that there is a connection with the vaccine. The doctors at OUH in Svendborg think the same, she says. The Funen nurse fully supports vaccines. Just not the one from Astrazeneca.
Avisendanmark report (paywall)
“We are dealing with a whole new syndrome, called WHITE. We have identified that there is an increased risk in using the vaccine. It gives us a figure on the increased risk with the serious disease cases. About 1 in 40,000 of those vaccinated with AstraZeneca’s vaccine are affected and many die,” says Søren Brostrøm.
“We know a lot more today than we did a month ago. We know that there is a possible biological explanation why AstraZeneca’s vaccine may cause these cases. This suggests a cross-reaction. We know that there is a temporal connection – we see cases 8-10 days after the vaccination, «says Søren Brostrøm, who gradually feels on safe scientific grounds when he now puts into words the Danish decision to stop using the vaccine.
“The causes of the death of Francesca Paola Vizzini, 75, who died on Sunday after the 118 doctors had tried in vain to revive her, are all to be clarified. His family presented a complaint to the carabinieri of the Uditore station and the Prosecutor’s Office opened an investigation, also arranging an autopsy, which was performed today.
Although the woman, as reported by her relatives, had received the Astrazeneca vaccine last Tuesday at the Fair, the deputy prosecutor Ennio Petrigni and the deputy Claudio Camilleri, who coordinate the investigation, have not yet involved the special task force. regional deputy to study hypothetical links between deaths and vaccines and this precisely because at the moment it is not known exactly what caused the death of the old woman, a fact that will have to be clarified by the autopsy.
The woman, who allegedly suffered from hypertension, had received the Astrazeneca vaccine last Tuesday and allegedly experienced the normal symptoms of fatigue and arm pain expected in these cases. In the evening she would also have a sense of nausea and her sister would have given her something against vomiting. A home cure that would have given its effects.
Subsequently, Vizzini would also have had a fever and, even in this case, she would have been given Tachipirina at home. On Saturday 10th, 118 would have been called for the first time, but the lady would have refused to go to the doctor or to the hospital. During the night she allegedly suffered abdominal pain and when an ambulance was called again on Sunday morning, attempts to revive her had proved futile. ”
A 26-year-old woman on April 13 was in fact hospitalized in a reserved prognosis at the Milan Polyclinic, after vaccination against Covid with AstraZeneca vaccine.
According to what is learned, the twenty-six year old is hospitalized at the Milan Polyclinic with cerebral thrombosis . The girl, according to the hospital, “is conscious and responds to therapies . She is in conditions considered stable, even if the prognosis remains confidential and is kept under close observation”. The hospitalization at the Milan Polyclinic was necessary because her situation was serious, also for this reason the patient was sent to the Thrombosis Center led by Flora Peyvandi, reference structure.
Stunning developments today in relation to the adenovirus vaccines now being marketed for Covid-19, including AstraZeneca’s Vaxevria, and the Johnson and Johnson Covid-19 vaccine. Are adenovirus vaccines now finished?
- The EU Commission has decided not to renew COVID-19 vaccine contracts with AstraZeneca and Johnson & Johnson – Reuters
- AstraZeneca vaccine: Denmark stops rollout completely – BBC report
- EMA to provide further context on risk of very rare blood clots with low blood platelets – EMA
- U.S. FDA to scrutinize vaccine design behind COVID-19 shots linked to blood clot – Reuters
Our opinion: The writing is on the wall for adenovirus vaccines as far as the Sars-cov-2 pandemic is concerned